$ Value
$1.7M
Shares
10,000
Price
$170
Filed
Jul 22
Insider
Name
RABINOWITZ DANIEL
Title
SEC. AND CHIEF LEGAL OFFICER
CIK
0001857843
Roles
Transaction Details
Transaction Date
2025-06-18
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
213,674
Footnotes
The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2024, as amended on March 14, 2025. | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $170.00 to $170.50 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $170.11 to $171.10 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $171.12 to $171.74 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. | The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 28, 2022. | The RSUs vest over four years. 25% of the RSUs vested on January 20, 2023 and the remaining shares vest in 12 equal quarterly installments thereafter.
Filing Info
RABINOWITZ DANIEL's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-01 | NTRA | ▼ | $60K |
| 2026-04-01 | NTRA | ▼ | $359K |
| 2026-04-01 | NTRA | ▼ | $652K |
| 2026-04-01 | NTRA | ▼ | $245K |
| 2026-04-01 | NTRA | ▼ | $391K |
| 2026-03-10 | NTRA | ▼ | $356K |
| 2026-03-09 | NTRA | A | — |
| 2026-03-06 | NTRA | M | $110K |
| 2026-03-06 | NTRA | ▼ | $77K |
| 2026-03-06 | NTRA | ▼ | $565K |
Other Insiders at NTRA (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| BOTHA ROELOF | — | — | 2026-01-30 |
| ROSENMAN HERM | — | — | 2026-01-30 |
| Williams Brinkley Ruth | — | — | 2026-01-30 |
|
Rabinowitz Matthew
EXECUTIVE CHAIRMAN
|
— | $38.3M | 2026-04-06 |
| Sheena Jonathan | — | $2.4M | 2026-04-17 |
| Baynes Roy D. | — | — | 2026-01-30 |
|
Brophy Michael Burkes
CHIEF FINANCIAL OFFICER
|
— | $2.9M | 2026-03-10 |
| Marcus Gail Boxer | — | — | 2026-01-30 |
|
Chapman Steven Leonard
CEO AND PRESIDENT
|
— | $24.1M | 2026-03-10 |
| Bertagnolli Monica | — | — | 2026-01-30 |
| Chapman Rowan E | — | $23K | 2026-03-13 |
|
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
|
— | $4.5M | 2026-04-01 |
|
Moshkevich Solomon
PRESIDENT, CLINICALDIAGNOSTICS
|
— | $3.0M | 2026-04-01 |
|
Fesko John
PRESIDENT, CHIEF BUS. OFFICER
|
— | $1.4M | 2026-03-10 |